|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.68 USD | +0.70% |
|
+5.84% | +10.46% |
| 12-22 | Darling Ingredients Sells $50 Million in Production Tax Credits | MT |
| 12-22 | Darling Ingredients announces sale of approximately $50 million in production tax credits | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.75 | 5.68 | 5.7 | 3.69 | 1.66 | |||||
Return on Total Capital | 2.12 | 6.97 | 7.03 | 4.46 | 1.94 | |||||
Return On Equity % | 10.73 | 20.86 | 20.63 | 15.38 | 6.24 | |||||
Return on Common Equity | 10.88 | 21.09 | 20.81 | 15.4 | 6.21 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.72 | 26.19 | 23.42 | 24.23 | 22.36 | |||||
SG&A Margin | 10.62 | 8.26 | 6.67 | 8.02 | 8.64 | |||||
EBITDA Margin % | 14.1 | 17.94 | 16.75 | 16.22 | 13.72 | |||||
EBITA Margin % | 6.37 | 12.69 | 12.06 | 10.66 | 6.86 | |||||
EBIT Margin % | 4.3 | 11.26 | 10.71 | 8.82 | 4.9 | |||||
Income From Continuing Operations Margin % | 8.41 | 13.86 | 11.44 | 9.73 | 5 | |||||
Net Income Margin % | 8.31 | 13.73 | 11.29 | 9.54 | 4.88 | |||||
Net Avail. For Common Margin % | 8.31 | 13.73 | 11.29 | 9.54 | 4.88 | |||||
Normalized Net Income Margin | 6.75 | 10.71 | 8.8 | 6.6 | 2.18 | |||||
Levered Free Cash Flow Margin | 3.81 | 6.98 | 2.43 | -1.3 | 9.55 | |||||
Unlevered Free Cash Flow Margin | 4.85 | 7.69 | 3.56 | 0.99 | 12.22 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.65 | 0.81 | 0.85 | 0.67 | 0.54 | |||||
Fixed Assets Turnover | 1.81 | 2.37 | 2.81 | 2.35 | 1.88 | |||||
Receivables Turnover (Average Receivables) | 8.8 | 10.84 | 11.4 | 9.21 | 8.23 | |||||
Inventory Turnover (Average Inventory) | 6.99 | 8.11 | 8.85 | 7.18 | 6.64 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.46 | 1.45 | 1.53 | 1.86 | 1.38 | |||||
Quick Ratio | 0.73 | 0.72 | 0.77 | 0.95 | 0.67 | |||||
Operating Cash Flow to Current Liabilities | 0.92 | 0.94 | 0.76 | 0.9 | 0.8 | |||||
Days Sales Outstanding (Average Receivables) | 42.15 | 33.57 | 31.92 | 39.54 | 44.23 | |||||
Days Outstanding Inventory (Average Inventory) | 53.04 | 44.9 | 41.15 | 50.69 | 54.78 | |||||
Average Days Payable Outstanding | 33.58 | 28.83 | 27.19 | 31.26 | 33.12 | |||||
Cash Conversion Cycle (Average Days) | 61.61 | 49.64 | 45.88 | 58.97 | 65.89 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 56.1 | 48.45 | 91.77 | 98.8 | 95.36 | |||||
Total Debt / Total Capital | 35.94 | 32.64 | 47.85 | 49.7 | 48.81 | |||||
LT Debt/Equity | 53.83 | 46.58 | 88.71 | 96.33 | 90.97 | |||||
Long-Term Debt / Total Capital | 34.48 | 31.38 | 46.26 | 48.45 | 46.57 | |||||
Total Liabilities / Total Assets | 47.37 | 45.42 | 57.66 | 57.57 | 55.67 | |||||
EBIT / Interest Expense | 2.11 | 8.6 | 5.57 | 2.31 | 1.1 | |||||
EBITDA / Interest Expense | 7.91 | 14.88 | 9.35 | 4.61 | 3.49 | |||||
(EBITDA - Capex) / Interest Expense | 4.06 | 10.46 | 6.24 | 2.46 | 2.18 | |||||
Total Debt / EBITDA | 2.88 | 1.76 | 3.04 | 3.88 | 4.81 | |||||
Net Debt / EBITDA | 2.74 | 1.68 | 2.94 | 3.78 | 4.72 | |||||
Total Debt / (EBITDA - Capex) | 5.62 | 2.5 | 4.56 | 7.27 | 7.7 | |||||
Net Debt / (EBITDA - Capex) | 5.35 | 2.39 | 4.4 | 7.07 | 7.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.18 | 32.74 | 37.77 | 3.92 | -15.81 | |||||
Gross Profit, 1 Yr. Growth % | 13.98 | 40.64 | 23.16 | 7.55 | -22.32 | |||||
EBITDA, 1 Yr. Growth % | 23.54 | 68.86 | 28.65 | 0.62 | -28.79 | |||||
EBITA, 1 Yr. Growth % | 46.03 | 164.43 | 31.03 | -8.17 | -45.79 | |||||
EBIT, 1 Yr. Growth % | 86.78 | 248.02 | 30.96 | -14.37 | -53.23 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -6.43 | 118.86 | 13.66 | -11.61 | -56.72 | |||||
Net Income, 1 Yr. Growth % | -5.05 | 119.3 | 13.33 | -12.2 | -56.94 | |||||
Normalized Net Income, 1 Yr. Growth % | 9.89 | 110.51 | 13.27 | -22.11 | -72.22 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -4.3 | 119.1 | 15.13 | -11.14 | -56.64 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.23 | 15.71 | 44.23 | 17.99 | -26.02 | |||||
Inventory, 1 Yr. Growth % | 11.84 | 12.7 | 47.25 | 12.64 | -23.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.32 | -0.74 | 32.71 | 18.6 | -6.89 | |||||
Total Assets, 1 Yr. Growth % | 5.02 | 9.27 | 50.03 | 20.2 | -8.96 | |||||
Tangible Book Value, 1 Yr. Growth % | 41.89 | 43.7 | -41.5 | 7.35 | 10.7 | |||||
Common Equity, 1 Yr. Growth % | 12.71 | 13.45 | 16.09 | 20.91 | -4.94 | |||||
Cash From Operations, 1 Yr. Growth % | 72.26 | 12.77 | 15.52 | 10.51 | -6.67 | |||||
Capital Expenditures, 1 Yr. Growth % | -22.08 | -2.14 | 42.75 | 41.95 | -40.15 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -483.64 | 143.22 | -52.02 | -155.39 | -720.09 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 2.19K | 110.64 | -36.29 | -71.09 | 940.32 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.68 | 18.72 | 35.23 | 19.65 | -6.46 | |||||
Gross Profit, 2 Yr. CAGR % | 9.14 | 26.61 | 31.61 | 15.09 | -8.6 | |||||
EBITDA, 2 Yr. CAGR % | 8.19 | 43.66 | 47.39 | 13.78 | -15.35 | |||||
EBITA, 2 Yr. CAGR % | 11.12 | 93.79 | 86.14 | 9.69 | -29.45 | |||||
EBIT, 2 Yr. CAGR % | 18.62 | 148.4 | 113.49 | 5.9 | -36.71 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 68.37 | 43.1 | 57.72 | 0.24 | -38.14 | |||||
Net Income, 2 Yr. CAGR % | 71.01 | 44.3 | 57.65 | -0.25 | -38.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | 54.19 | 51.15 | 54.42 | -6.07 | -53.48 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 72.24 | 44.8 | 58.82 | 1.15 | -37.93 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.52 | 7.44 | 29.19 | 30.45 | -6.57 | |||||
Inventory, 2 Yr. CAGR % | 9.1 | 12.27 | 28.82 | 28.79 | -7.46 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.14 | 1.76 | 14.77 | 25.45 | 5.08 | |||||
Total Assets, 2 Yr. CAGR % | 7.15 | 7.12 | 28.04 | 34.29 | 4.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 60.77 | 42.79 | -8.31 | -20.75 | 9.01 | |||||
Common Equity, 2 Yr. CAGR % | 12.79 | 13.08 | 14.77 | 18.48 | 7.21 | |||||
Cash From Operations, 2 Yr. CAGR % | 25.18 | 39.38 | 14.14 | 12.99 | 1.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.72 | -12.68 | 18.19 | 42.35 | -7.83 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 26.41 | 218.04 | 8.03 | -48.45 | 85.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.96 | 494.29 | 15.84 | -57.09 | 73.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.83 | 11.86 | 24.76 | 23.86 | 6.42 | |||||
Gross Profit, 3 Yr. CAGR % | 3.93 | 18.77 | 25.45 | 23.04 | 0.95 | |||||
EBITDA, 3 Yr. CAGR % | 4.71 | 25.5 | 38.47 | 29.78 | -2.68 | |||||
EBITA, 3 Yr. CAGR % | 1.97 | 48.34 | 70.09 | 47.08 | -13.28 | |||||
EBIT, 3 Yr. CAGR % | 3.96 | 69.82 | 100.67 | 57.44 | -19.35 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 31.08 | 83.75 | 32.53 | 30.04 | -24.24 | |||||
Net Income, 3 Yr. CAGR % | 32.2 | 85.79 | 33.14 | 29.71 | -24.61 | |||||
Normalized Net Income, 3 Yr. CAGR % | 89.15 | 71.05 | 37.29 | 22.92 | -37.42 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 32.22 | 86.63 | 34.15 | 30.87 | -23.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.14 | 6.74 | 18.52 | 25.34 | 7.98 | |||||
Inventory, 3 Yr. CAGR % | 4.26 | 10.29 | 22.89 | 23.18 | 8.04 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.9 | 5.74 | 11.18 | 16.03 | 13.59 | |||||
Total Assets, 3 Yr. CAGR % | 4.22 | 7.85 | 19.85 | 25.37 | 17.97 | |||||
Tangible Book Value, 3 Yr. CAGR % | 63.01 | 54.87 | 6.05 | -3.36 | -11.41 | |||||
Common Equity, 3 Yr. CAGR % | 8.81 | 13.01 | 14.08 | 16.78 | 10.09 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.03 | 20.9 | 30.92 | 12.91 | 6.01 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.72 | -5.21 | 2.87 | 25.64 | 6.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 3.86 | 57.23 | 69.31 | -13.53 | 18.12 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.1 | 40.67 | 182.31 | -27.07 | 24.2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.04 | 6.93 | 12.27 | 14.91 | 11.18 | |||||
Gross Profit, 5 Yr. CAGR % | 3.68 | 10.42 | 14.23 | 17.28 | 10.52 | |||||
EBITDA, 5 Yr. CAGR % | 3.66 | 14.19 | 20.06 | 20.67 | 13.73 | |||||
EBITA, 5 Yr. CAGR % | -0.58 | 21.65 | 29.72 | 31.47 | 19.62 | |||||
EBIT, 5 Yr. CAGR % | 0.33 | 29.25 | 38.63 | 40.59 | 26.48 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 28.63 | 43.71 | 41.15 | 44.19 | -2.29 | |||||
Net Income, 5 Yr. CAGR % | 30.46 | 44.78 | 41.85 | 44.87 | -2.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | 30.73 | 49.66 | 74.4 | 34.59 | -10.95 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 30.19 | 44.46 | 42.28 | 46.07 | -1.44 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.77 | 3.85 | 11.54 | 15.66 | 7.77 | |||||
Inventory, 5 Yr. CAGR % | 3.33 | 6.7 | 13.46 | 17.34 | 9.71 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.92 | 5.66 | 9.98 | 13.22 | 8.7 | |||||
Total Assets, 5 Yr. CAGR % | 3.35 | 5.48 | 13.17 | 17.74 | 13.51 | |||||
Tangible Book Value, 5 Yr. CAGR % | 51.57 | 116.27 | 29.5 | 18.46 | 7.23 | |||||
Common Equity, 5 Yr. CAGR % | 9.1 | 10.71 | 11.15 | 15.17 | 11.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.21 | 12.49 | 14.67 | 17.67 | 18.27 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.03 | 2.4 | 7.37 | 11.53 | -1.55 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -6.14 | 20.49 | 5.51 | 0.65 | 75.54 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -5.68 | 15.49 | 6.76 | -12.51 | 132.31 |
- Stock Market
- Equities
- DAR Stock
- Financials Darling Ingredients Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















